Anti-inflammatory Effects of Colchicine in PCI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 280 participants.

Also called NCT01709981

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 280 participants (enrolled count) (from the registry)
Sponsor
  • NYU Langone Health Registry lists this organization as the lead sponsor
  • Takeda Registry lists this organization as a collaborator
Registry
  • NCT NCT01709981
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01709981. Randomized; quadruple masking; primary purpose treatment. Start 2013-05-30 (actual); primary completion 2019-08-30 (actual). Results posted on 2020-09-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Anti-inflammatory Effects of Colchicine in PCI
Intervention (Drug)
Colchicine
Intervention (Drug)
Placebo
Lead sponsor
NYU Langone Health (class: other)
Collaborator
Takeda (class: industry)

Record details

Record id
cardio:ct-nct01709981
Content hash
4e17635fe673b5257b0b44568c9ae7bc0648ad8a49bcb5a85412f139f0ae2255